Search

Author/Creator Lin, Yu-Lin

11. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study. Issue 1 (December 2016)

Authors:
Chen, Kuo-Hsing; Shao, Yu-Yun; Chen, Ho-Min; Lin, Yu-Lin; Lin, Zhong-Zhe; Lai, Mei-Shu; Cheng, Ann-Lii; Yeh, Kun-Huei
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. RNF43 Is an Early and Specific Mutated Gene in the Serrated Pathway, With Increased Frequency in Traditional Serrated Adenoma and Its Associated Malignancy. (October 2016)

Authors:
Tsai, Jia-Huei; Liau, Jau-Yu; Yuan, Chang-Tsu; Lin, Yu-Lin; Tseng, Li-Hui; Cheng, Mei-Ling; Jeng, Yung-Ming
Journal:
American journal of surgical pathology
Issue:
Volume 40:Number 10(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Traditional Serrated Pathway–associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations. (August 2019)

Authors:
Tsai, Jia-Huei; Jeng, Yung-Ming; Yuan, Chang-Tsu; Lin, Yu-Lin; Cheng, Mei-Ling; Liau, Jau-Yu
Journal:
American journal of surgical pathology
Issue:
Volume 43:Number 8(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗